Clinical trial Recruiting at 1 site Interventional Ages 17 to 20

ACL injury prevention program for 17–20-year-old athletes in Brno

Official title: Anterior Cruciate Ligament Injury Prevention Program ESSKA/ESMA: A Comprehensive Approach to Reducing the Incidence of Knee Joint Injuries in Czech Sport

Run by Masaryk University · NCT07019727 · Data updated 2026-11-12

This project will try a structured ESSKA/ESMA 'ACL Prevention for ALL' program with targeted exercises and 2D motion analysis to reduce ACL injuries in 17–20-year-old athletes who play high-risk sports.

Quick facts

Study typeInterventional
Ages17 Years to 20 Years
SexAll
Enrollment100 (estimated)
SponsorMasaryk University
Academic / other
Locations1 site (Brno)
StatusRecruiting
StartedJune 12, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedSeptember 30, 2025
Trial IDNCT07019727 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 17–20-year-old athletes engaged in sports with a high risk of ACL injury who have no current disabling knee injury, can attend regular training and testing sessions, and can provide informed consent.

Probably not a fit

Those with a current knee injury requiring treatment or surgery, significant chronic medical or neuromuscular conditions, or who cannot participate regularly are unlikely to benefit from the prevention program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program implements the evidence-based 'ACL Prevention for ALL' approach focused on muscle strengthening, flexibility, coordination, and safe movement technique delivered by a multidisciplinary team of coaches, physiotherapists, and physicians. Participants follow targeted exercise modules and education sessions, and undergo dynamic evaluations including 2D motion analysis of jumps and landings to identify biomechanical and muscle imbalances. Individualized training plans are created from the assessment data to correct deficits and improve movement safety. The project is carried out at Masaryk University and affiliated hospitals in Brno with the aim of reducing ACL injury incidence among adolescent athletes.

Why it matters

Potential benefit: If successful, the program could substantially lower ACL injury risk, improve movement safety, and help athletes continue sports with fewer knee problems.

How similar studies have gone: Similar implementations of the ‘ACL Prevention for ALL’ concept have demonstrated large reductions in ACL injuries (approximately 50–60%) across ages and competition levels, so the approach is supported by prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age group: Participants aged 17-20 years

Sports activity: Individuals actively engaged in sports with a high risk of ACL injury

Health status: Participants with no or minimal previous knee joint injuries that do not limit their current physical activity

Willingness to participate: Agreement to take part in the prevention program, including regular training and assessments

Informed consent: Signed informed consent for participation in the program and testing procedures; for minors, consent must be signed by legal guardians

Exclusion Criteria:

Current injury: Individuals with a current knee joint injury requiring treatment or surgery

Chronic conditions: Participants with chronic diseases or conditions that may affect the outcome of injury prevention (e.g., congenital abnormalities, neuromuscular disorders, or cardiovascular diseases)

Insufficient consent: Individuals who are unable or unwilling to provide written informed consent

Irregular participation: Individuals who do not comply with regular participation in the training program or assessments

Where it's running

  • Faculty of Medicine, Masaryk University
    Brno, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.